MD Anderson Cancer Center at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
MD Anderson Cancer Center brings 13 presentations to AMP 2026 in Seattle. Its program centres on measurable residual disease detection, transcriptomic and genomic profiling of leukaemias and lymphomas, and how far AI models can be trusted in molecular testing. Its liquid biopsy work includes clonal haematopoiesis found by paired plasma and blood testing in patients with solid tumours.
| Organization | AMP 2026 Attendance |
|---|---|
MD Anderson Cancer Center Houston, TX | |
Comprehensive cancer center and academic medical institution in Houston, with clinical molecular diagnostics laboratories. | Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Workshop Wed, Nov 11 2:00pm–2:50pm Unlocking AML Biology with 5-Base Whole-Genome Sequencing: Integrated Genomic and Epigenomic Profiling for Biomarker Discovery Five-base whole-genome sequencing reads methylation and genomic variation from one AML sample to find research biomarkers. Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias
Workshop Thu, Nov 12 12:00pm–12:30pm AMP Practice Guidelines Meet the Authors Series: Lung Guideline Update New lung cancer molecular testing recommendations from the updated joint practice guideline, with the evidence and process behind them. Session Fri, Nov 13 10:15am–11:45am Accelerating the Impact of Molecular Profiling in Pediatric and Adolescent Young Adult (AYA) Tumors
Session Fri, Nov 13 1:15pm–2:45pm Menin Inhibitors and Targeted Therapy Resistance in AML
Workshop Fri, Nov 13 9:30am–10:00am Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies Electronic genome mapping weighed against karyotyping, FISH and optical mapping for structural variants, including marrow versus blood samples. Talk Sat, Nov 14 10:15am–11:00am From AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing? How well DNA foundation models actually perform on clinical genomic tasks, and how to judge which ones to trust. Talk Sat, Nov 14 10:15am–11:00am Poster Sat, Nov 14 1:45pm–2:00pm Session Sat, Nov 14 2:30pm–4:00pm Technical Advances in Molecular Measurable Residual Disease Detection in Hematologic Neoplasms
Talk Sat, Nov 14 3:00pm–3:30pm Direct DNA Methylation Analysis by Single Molecule Real-Time Sequencing A transformer model reads polymerase kinetics from SMRT sequencing to call 5mC, 5hmC and 6mA base modifications directly. |
Instantly find 20 buyers from MD Anderson Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction